Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | CDC14B | O60729 | 2/20 | 0.36 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 3/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25577681 | 0.95 | ALOX5 (0.44) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL25577656 | 0.94 | ALOX5 (0.47) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL25577620 | 0.94 | ALOX5 (0.39) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL24840128 | 0.93 | ALOX5 (0.43) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL25577371 | 0.93 | ALOX5 (0.38) | ALOX5CDC14BCDC14AGGPS1BACE1 | |
| SCHEMBL25579373 | 0.93 | ALOX5 (0.46) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL25579390 | 0.93 | ALOX5 (0.46) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL25579465 | 0.93 | ALOX5 (0.46) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL25577674 | 0.93 | BACE1 (0.33) | ALOX5CDC14BCDC14ABACE1CYP19A1 | |
| SCHEMBL25580772 | 0.92 | ALOX5 (0.43) | ALOX5CDC14BCDC14AGGPS1PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | ESR1, L1CAM, ESR2 | ALOX5 1615/4885CDC14B 4631/4885CDC14A 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.